Please download the dossier by clicking on the dossier button x
×

Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1

  • US 9,498,467 B2
  • Filed: 05/29/2015
  • Issued: 11/22/2016
  • Est. Priority Date: 05/30/2014
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a leukemia selected from chronic neutrophilic leukemia and atypical chronic myeloid leukemia in a patient in need thereof, comprising administering to said patient a therapeutically effective amount of a selective JAK1 inhibitor.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×